Verzenio was approved for a similar adjuvant indication last year, having been used for a couple of years only in patients ...

Giredestrant has a stronger anti-proliferative effect than anastrozole in patients with estrogen receptor-positive, HER2-negative, previously untreated early breast cancer, a new study suggests.

The breast cancer drug Ibrance (palbociclib), ranked eighth, has emerged as a big earner for Pfizer, which is testing the drug on several other cancers. "Johnson & Johnson and Mitsubishi Tanabe ...

During a Case-Based Roundtable® event, Virginia F. Borges, MD, MMSc, discussed treatment selection for a patient with ER+, ...

As every investor would know, not every swing hits the sweet spot. But really bad investments should be rare. So take a... On August 30, 2024, Vanguard Group Inc made a significant addition to its ...

Financial Services Secretary M Nagaraju, who was also present at the ceremony, expressed his happiness with the bank's initiative.

After hours: September 19 at 5:15 PM EDT Loading Chart for OLMA ...